Related Experiment Video
Updated: Oct 21, 2025
Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Flavin-containing monooxygenase 1 deficiency promotes neuroinflammation in dopaminergic neurons in mice
Boyu Li1, Song Yang1, Junrui Ye2
1Department of Pharmacy, Beijing Chao-Yang Hospital, Capital Medical University, 8 Gongtinan Road, Beijing 100020, China.
Abstract:
A growing body of evidence indicates an association between flavin-containing monooxygenase (FMO) and neurodegeneration, including Parkinson's disease (PD); however, the details of this association are unclear. We previously showed that the level of Fmo1 mRNA is decreased in an in vitro rotenone model of parkinsonism. To further explore the potential involvement of FMO1 deficiency in parkinsonism, we generated Fmo1 knockout (KO) mice and examined the survival of dopaminergic neurons and relative changes. Fmo1 KO mice exhibited loss of tyrosine hydroxylase-positive neurons, decreased levels of tyrosine hydroxylase and Parkin proteins, and increased levels of pro-inflammatory cytokines (IL1β and IL6) in the nigrostriatal region. Moreover, the protein levels of PTEN induced kinase 1 (PINK1) and p62, and the Microtubule associated protein 1 light chain 3 (LC3)-II/I ratio were not significantly altered in Fmo1 KO mice (P > 0.05). FMO1 deficiency promotes neuroinflammation in dopaminergic neurons in mice, thus may plays a potential pathological role in dopaminergic neuronal loss. These findings may provide new insight into the pathogenesis of PD.
Insights
Flavin-containing monooxygenase 1 (FMO1) deficiency in mice leads to neuroinflammation and loss of dopaminergic neurons, suggesting a role in Parkinson's disease pathogenesis.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Growing evidence links flavin-containing monooxygenase (FMO) to neurodegeneration, including Parkinson's disease (PD).
- Previous studies showed decreased Fmo1 mRNA in an in vitro rotenone model of parkinsonism.
- The precise role of FMO1 in PD pathogenesis remains unclear.
Purpose of the Study:
- To investigate the potential involvement of flavin-containing monooxygenase 1 (FMO1) deficiency in parkinsonism.
- To examine the effects of FMO1 deficiency on dopaminergic neuron survival and related molecular changes in a mouse model.
Main Methods:
- Generation of Fmo1 knockout (KO) mice.
- Analysis of dopaminergic neuron survival in the nigrostriatal region.
- Quantification of protein levels (tyrosine hydroxylase, Parkin, PINK1, p62, LC3) and pro-inflammatory cytokines (IL1β, IL6).
Main Results:
- Fmo1 KO mice exhibited loss of tyrosine hydroxylase-positive neurons.
- Decreased levels of tyrosine hydroxylase and Parkin proteins were observed in Fmo1 KO mice.
- Increased levels of pro-inflammatory cytokines (IL1β and IL6) were found in the nigrostriatal region of Fmo1 KO mice, while PINK1, p62, and LC3-II/I ratio remained unchanged.
Conclusions:
- Flavin-containing monooxygenase 1 (FMO1) deficiency promotes neuroinflammation in dopaminergic neurons in mice.
- FMO1 deficiency may play a pathological role in the loss of dopaminergic neurons.
- These findings offer new insights into the pathogenesis of Parkinson's disease.
